Organogenesis Holdings Inc. to Release Q1 Fiscal Year 2026 Financial Results on May 7, 2026

Organogenesis Holdings Inc. announced plans to release its financial results for the first quarter of fiscal year 2026 on May 7, 2026. The company confirmed that it will provide detailed insights into its performance during this period, with the report expected to include key financial metrics and updates on business operations.

The announcement was made on April 6, 2026, and follows the company’s regular practice of quarterly reporting. Organogenesis Holdings Inc., a leader in regenerative medicine and advanced wound care solutions, has not disclosed specific details about what the report will cover but is anticipated to share information relevant to shareholders and stakeholders. Further updates are expected to be available through official channels following the release date.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 6, 2026

Author

GOAI